Background

Baur JA & Sinclair DA (2006). Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5, 493-506.

View Publication

Moussa C, Hebron M, Huang X, Ahn J, Rissman RA, Aisen PS, Turner RS, (2017) Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease. Journal of Neuroinflammation. 14(1):1.

View Publication

Shin S, Jeon JH, Park D, Jang MJ, Choi JH, Choi BH, Joo SS, Nahm SS, Kim JC, & Kim YB. (2008). trans-Resveratrol relaxes the corpus cavernosum ex vivo and enhances testosterone levels and sperm quality in vivo. Arch Pharm Res 31, 83-87.

View Publication

Turner RS, Thomas, RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, Brewer JB, Rissman RA, Raman R, Aisen PS, et al. (2015). A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology 85, 1383-1391.

View Publication

Wu RE, Huang WC, Liao CC, Chang YK, Kan NW, & Huang CC (2013). Resveratrol protects against physical fatigue and improves exercise performance in mice. Molecules 18, 4689-4702.

View Publication

Yiu EM, Tai G, Peverill RE, Lee KJ, Croft KD, Mori TA, Scheiber-Mojdehkar B, Sturm B, Praschberger M, Vogel AP, et al. (2015). An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels. J Neurol 262, 1344-1353.

View Publication

Get in touch

Powered by WordPress. Designed by WooThemes